financetom
Business
financetom
/
Business
/
Buffett strongly backs CEO-designate Abel; to speed up donations
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Buffett strongly backs CEO-designate Abel; to speed up donations
Nov 10, 2025 10:29 AM

Nov 10 (Reuters) - Warren Buffett on Monday gave a

full-throated endorsement to Greg Abel, who will replace him as

Berkshire Hathaway's ( BRK/A ) chief executive in January, and

said he will continue holding a significant number of Berkshire

shares to reassure shareholders about the changeover.

In a letter to Berkshire shareholders, possibly his last

public communication with them until he steps down, Buffett, 95,

said Abel has "more than met" his high expectations when he

first thought the 63-year-old was CEO material.

"I can't think of a CEO, a management consultant, an

academic, a member of government - you name it - that I would

select over Greg to handle your savings and mine," wrote

Buffett, who will remain Berkshire's chairman.

Buffett also said he will speed up his charitable donations

to family foundations led by his daughter Susie, 72, and sons

Howard, 70, and Peter, 67, but that it "in no way reflects any

change in my views about Berkshire's prospects."

Buffett also donated more than $1.3 billion of Berkshire

stock, the equivalent of 1,800 Class A shares, to four family

foundations led by his children.

They will also oversee a charitable trust that will contain

nearly all of Buffett's remaining wealth after he dies.

Potential successor trustees have been named if they cannot

serve.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BioMarin Pharmaceutical to Acquire Inozyme Pharma for $270 Million
BioMarin Pharmaceutical to Acquire Inozyme Pharma for $270 Million
May 26, 2025
07:55 AM EDT, 05/16/2025 (MT Newswires) -- BioMarin Pharmaceutical ( BMRN ) said Friday that it has agreed to acquire Inozyme Pharma ( INZY ) at $4 per share in cash for a total price of $270 million. The biotech company said the deal is expected to close in Q3, which is contingent on regulatory approval, completion of a tender...
US STOCKS-Wall Street eyes strong weekly gains as trade deal, inflation ease jitters
US STOCKS-Wall Street eyes strong weekly gains as trade deal, inflation ease jitters
May 26, 2025
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.) * Futures up: Dow 0.33%, S&P 500 0.31%, Nasdaq 0.34% * Charter Communications ( CHTR ) to merge with Cox * UnitedHealth ( UNH ) up after dropping 11% on Thursday (Updates with analyst comment) By Shashwat Chauhan and...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Top Premarket Decliners
Top Premarket Decliners
May 26, 2025
07:53 AM EDT, 05/16/2025 (MT Newswires) -- Globant ( GLOB ) shares slumped 28% pre-bell Friday after the company reported late Thursday lower Q1 adjusted earnings and cut its 2025 financial guidance. Doximity ( DOCS ) shares fell 19%, a day after the company issued revenue guidance for fiscal Q1 and fiscal 2026 that trailed analysts' projections. Widepoint Corp. (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved